The LDN book : how a little-known generic drug, low dose naltrexone, could revolutionize treatment for autoimmune diseases, cancer, autism, depression, and more
Record details
- ISBN: 9781603586641
- ISBN: 1603586644
- ISBN: 9781603586658
-
Physical Description:
print
xix, 214 pages ; 23 cm - Publisher: White River Junction, Vermont : Chelsea Green Publishing, [2016]
Content descriptions
Bibliography, etc. Note: | Includes bibliographical references and index. |
Formatted Contents Note: | The history and pharmacology of LDN / by J. Stephen Dickson -- Multiple sclerosis and lupus / by Deanna Windham -- Inflammatory bowel disease / by Jill P. Smith and Leonard B. Weinstock -- Chronic fatigue syndrome and fibromyalgia / by Kent Holtorf -- Thyroid disorders / by Kent Holtorf -- Restless legs syndrome / by Leonard B. Weinstock and Trisha L. Myers -- Depression / by Mark Shukhman and Rebecca Shukhman -- Autism spectrum disorder / by Brian D. Udell -- Cancer / by Angus G. Dalgleish with Wai M. Liu. |
Search for related items by subject
Subject: | Naltrexone Therapeutic use Naltrexone therapeutic use Naltrexone pharmacology Dose-Response Relationship, Drug Narcotic Antagonists therapeutic use Opioid Peptides metabolism |
Available copies
- 1 of 1 copy available at Kirtland Community College.
Holds
- 0 current holds with 1 total copy.
Show Only Available Copies
Location | Call Number / Copy Notes | Barcode | Shelving Location | Status | Due Date |
---|---|---|---|---|---|
Kirtland Community College Library | RM 328 .L36 2016 | 30775305507940 | General Collection | Available | - |
The LDN Book : How a Little-Known Generic Drug -- Low Dose Naltrexone -- Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More
Click an element below to view details:
Table of Contents
The LDN Book : How a Little-Known Generic Drug -- Low Dose Naltrexone -- Could Revolutionize Treatment for Autoimmune Diseases, Cancer, Autism, Depression, and More
Section | Section Description | Page Number |
---|---|---|
Preface Linda Elsegood | p. ix | |
Introduction Jill Cottel | p. xv | |
Chapter 1 | The History and Pharmacology of LDN J. Stephen Dickson | p. 1 |
Chapter 2 | Multiple Sclerosis and Lupus Deanna Windham | p. 25 |
Chapter 3 | Inflammatory Bowel Disease Jill P. Smith and Leonard B. Weinstock | p. 55 |
Chapter 4 | Chronic Fatigue Syndrome and Fibromyalgia Kent Holtorf | p. 69 |
Chapter 5 | Thyroid Disorders Kent Holtorf | p. 81 |
Chapter 6 | Restless Legs Syndrome Leonard B. Weinstock and Trisha L. Myers | p. 99 |
Chapter 7 | Depression Mark Shukhman and Rebecca Shukhman | p. 111 |
Chapter 8 | Autism Spectrum Disorder Brian D. Udell | p. 131 |
Chapter 9 | Cancer Angus C. Dalgleish and Wai M. Liu | p. 143 |
Acknowledgments | p. 152 | |
Appendix A | Starting the Conversation Mark H. Mandel | p. 153 |
Appendix B | Frequently Asked Questions about LDN Skip Lenz and Julia Schopick | p. 157 |
Notes | p. 165 | |
Contributors | p. 199 | |
Index | p. 209 |